The week ending October 9, 2026 was quiet for headline venture rounds in the DMV, but the deals that did land point to two of the region's deepest strengths: defense hardware in Northern Virginia and cell and gene therapy science in Maryland. A Herndon defense startup closed a $17.5M round to scale production, a Germantown biotech raised $11.2M ahead of a merger, and a Johns Hopkins spinout in Baltimore paired an undisclosed pre-seed round with its first federal research grant. We did not find a verified, newly announced venture round for a DC-based startup this week, so this roundup covers three deals across Virginia and Maryland.
Never miss a DMV deadline. Get the weekly list of DMV startup events, grants and deadlines. Join the StartDMV list at https://startdmv.org.
This week's deals
Photo via Magnific
Deals below were announced between October 3 and October 9, 2026. Amounts are as reported by the company or by the outlet linked in the Source column. Where a figure or a lead investor was not disclosed, we say so.
| Company | City | What they do | Deal | Amount | Lead investors | Source |
|---|---|---|---|---|---|---|
| Aventra | Herndon, VA | Piranha, a balloon-launched autonomous glider that carries sensors or payloads over long distances | Strategic funding round plus a bank funding facility | $17.5M | Konvoy | Defense Daily |
| Seraxis (merging with Sernova to form BetaNova Biotherapeutics) | Germantown, MD | Stem cell-derived pancreatic islet therapies for type 1 diabetes | Convertible notes and warrants financing ahead of a merger | $11.2M | Not disclosed; insiders, existing shareholders and new investors participated | BioBuzz |
| SereNeuro Therapeutics | Baltimore, MD | Non-opioid cell and gene therapies for chronic pain | Oversubscribed pre-seed round plus an NIH SBIR grant | Round size undisclosed; SBIR grant of $318,000 | Not disclosed | Technical.ly |
Deal notes
Aventra raises $17.5M to scale Piranha production in Herndon
Aventra is building Piranha, a low-cost autonomous fixed-wing glider that is released from a high-altitude balloon and can carry sensors or a warhead. Defense Daily reports that the system can launch from up to 80,000 feet and travel about 1,000 kilometers, and that Konvoy led the round with funds going to flight testing and production. Lavrock Ventures, Booz Allen Ventures, Sands Capital and Langford Industries also participated, Western Alliance Bank provided a funding facility, and the company says it plans to expand manufacturing capacity in Herndon. The round comes roughly a year after Aventra came out of stealth with a $3M seed round.
Seraxis closes $11.2M ahead of its BetaNova merger
Germantown-based Seraxis develops pancreatic islet cells grown from stem cells and made under cGMP manufacturing, led by its SR-02 program and a gene-edited follow-on called SR-03. According to BioBuzz, Seraxis and Sernova closed an $11.2M non-brokered financing of convertible notes and warrants, above an earlier $10M target, and the notes are expected to convert into stock of BetaNova Biotherapeutics when the two companies complete their merger. No lead investor was named; participants included insider Dr. Steven Sangha through Arlo Investments, management of both companies, existing shareholders and new investors.
SereNeuro closes pre-seed and wins its first NIH SBIR award
SereNeuro Therapeutics, a Johns Hopkins spinout based in East Baltimore, is developing SN101, an injectable therapy made of lab-grown human pain-sensing neurons that acts as a pain sponge inside arthritic joints, plus SN102, a gene therapy for nerve pain. BioBuzz reports the pre-seed round was oversubscribed and that qualifying investors used Maryland's Biotechnology Investment Incentive Tax Credit, but the round size and investors were not disclosed. Technical.ly reports the company also received a $318,000 Small Business Innovation Research grant from the National Institutes of Health.
What this week signals
Defense hardware keeps pulling capital into Northern Virginia. Aventra follows a run of national security rounds in Arlington, Chantilly and the Dulles corridor, and its cap table shows the local pattern well: a lead from outside the region, plus a corporate venture arm from a Northern Virginia prime contractor in Booz Allen Ventures. When defense startups say they will add manufacturing near Dulles, it signals that founders see value in being close to government customers and to cleared talent.
Maryland's life sciences pipeline is being financed with creative structures rather than large priced rounds. Seraxis used convertible notes tied to a merger, and SereNeuro combined private capital, a state tax credit and non-dilutive federal grant money. For early biotech founders in the region, the lesson is that state programs such as the Biotechnology Investment Incentive Tax Credit and federal SBIR awards can stretch a small round much further than equity alone.
The biggest Maryland money headline of the week was not a venture deal. The Baltimore Sun, via Yahoo Finance, reported that Maryland and Baltimore County are preparing up to $481M in public support for Anduril's planned $3.7B submarine manufacturing complex at Sparrows Point. If it moves forward, it could pull defense suppliers and hardware startups toward the Baltimore area over the next several years.
DC itself was quiet. A slow week is normal, and founders in the District should keep an eye on local programs and investors that back early-stage companies.
Is your startup on StartDMV?
StartDMV tracks the founders, investors and support organizations building companies across DC, Maryland and Northern Virginia. If your startup is not listed yet, add it to the directory so investors, partners and talent can find you, and so we can include your next raise, grant or acquisition in this weekly roundup. Visit StartDMV to list your startup and to join the weekly newsletter of DMV events, grants and deadlines.